# Invivyd, Inc. (IVVD)

> Source: Nexqual · https://nexqual.com/IVVD · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Invivyd, Inc. (IVVD), nexqual.com/IVVD" · informational, not investment advice.

**Price:** USD 0.67 (+10.04% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 0.61 · day 0.61–0.68 · 52w 0.53–3.07 · market cap $197M · NGM

## Key facts
- 1 of 80 tracked superinvestors hold IVVD (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (3 analysts), mean target USD 10 (range 10–10).
- Total return with dividends: 1Y -61.8% vs S&P 500 +18.1%; 5Y -97.9% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD -0.15, revenue estimate $15.0M.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold IVVD. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Lee Ainslie | Maverick Capital | 0.15% | $16.6M | Unchanged |

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 3 analysts; mean target USD 10 (low 10, high 10).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-14 | BTIG | Reiterated | Buy | $10 |
| 2026-08-27 | Cantor Fitzgerald | Reiterated | Overweight | $10 |
| 2026-07-07 | BTIG | Reiterated | Buy | $10 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -61.8% | -97.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -61.9% | -53.9% |
| Volatility (annualized) | 107.8% | 146.4% |
| Max drawdown | -81.4% (Dec 2025→Jul 2026) | -99.2% (Nov 2021→Jan 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/IVVD · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt